Basic Information
RNALocate ID: RLID:11004414
RNA Symbol: hsa-miR-1915-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-1915
RNA ID: miRBase:MIMAT0007892
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 24468161
Tissue/Cell Line: Breast cancer cell lines (MCF-7|MDA-MB-231)
Method: Microarray

Originally published in BMC Cancer. Kruger S, et al, 2014. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)
Description: Differential gene expression in exosome-like vesicles. A) Hierarchical clustering was used to display miRNAs differentially expressed in each vesicle type. The extent of green (decreased fold change) or red (increased fold change) colors is directly proportional to the magnitude of differential expression of miRNAs. B) miRNA profiles of the MDA-Exo versus MCF-Exo. Bars represent fold change of hybridization signals in MDA-Exo against MCF-Exo. Blue and red bars display relatively higher miRNA expressions in MDA-Exo and MCF-Exo, respectively. Data are collected from Figure 3.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11004412 Exosome Pooled sera 27278097
RLID:11004413 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11004415 Microvesicle Seminal plasma 23539611
RLID-D:11001766 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
RLID-D:11004211 Microvesicle Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-1915-3p Multiple sclerosis chronic progressive MNDR-E-MI-22485
MNDR hsa-miR-1915-3p Estrogen-receptor positive breast cancer MNDR-E-MI-22486
MNDR hsa-miR-1915-3p Estrogen-receptor negative breast cancer MNDR-E-MI-22487
MNDR hsa-miR-1915-3p Progesterone-receptor positive breast cancer MNDR-E-MI-22488
MNDR hsa-miR-1915-3p Progesterone-receptor negative breast cancer MNDR-E-MI-22489
MNDR hsa-miR-1915-3p Colorectal carcinoma MNDR-E-MI-22490
MNDR hsa-miR-1915-3p Gastric cancer MNDR-E-MI-22491
MNDR hsa-miR-1915-3p Intracranial aneurysm MNDR-E-MI-22492
MNDR hsa-miR-1915-3p Focal segmental glomerulosclerosis MNDR-E-MI-22493
MNDR hsa-miR-1915-3p Parkinson disease MNDR-E-MI-22494
MNDR hsa-miR-1915-3p Breast cancer MNDR-E-MI-22495
MNDR hsa-miR-1915-3p Pancreatic cancer MNDR-E-MI-22496
MNDR hsa-miR-1915-3p Nephroblastoma MNDR-E-MI-22497
MNDR hsa-miR-1915-3p Colon cancer MNDR-E-MI-22498
MNDR hsa-miR-1915-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-22499
MNDR hsa-miR-1915-3p Ovarian cancer MNDR-E-MI-22500
MNDR hsa-miR-1915-3p Invasive ductal carcinoma MNDR-E-MI-22501
MNDR hsa-miR-1915-3p Glioblastoma MNDR-E-MI-22502
MNDR hsa-miR-1915-3p Chordoma MNDR-E-MI-22503
MNDR hsa-miR-1915-3p Amyotrophic lateral sclerosis MNDR-E-MI-22504
MNDR hsa-miR-1915-3p Meningioma MNDR-E-MI-22505
MNDR hsa-miR-1915-3p Liver cancer MNDR-E-MI-22506
MNDR hsa-miR-1915-3p Lung adenocarcinoma MNDR-E-MI-22507
MNDR hsa-miR-1915-3p Biliary tract cancer MNDR-E-MI-22508
MNDR hsa-miR-1915-3p Cholangiocarcinoma MNDR-E-MI-22509
MNDR hsa-miR-1915-3p Esophageal cancer MNDR-E-MI-22510
MNDR hsa-miR-1915-3p Lung small cell carcinoma MNDR-E-MI-22511
MNDR hsa-miR-1915-3p Progressive supranuclear palsy MNDR-E-MI-22512
MNDR hsa-miR-1915-3p Hepatocellular carcinoma MNDR-E-MI-22513
MNDR hsa-miR-1915-3p Hodgkin lymphoma MNDR-E-MI-22514
MNDR hsa-miR-1915-3p Colorectal cancer MNDR-E-MI-22515
MNDR hsa-miR-1915-3p Nasopharynx carcinoma MNDR-E-MI-22516
MNDR hsa-miR-1915-3p Nasopharyngeal cancer MNDR-E-MI-22517
MNDR hsa-miR-1915-3p Stroke lacunar MNDR-E-MI-22518
MNDR hsa-miR-1915-3p Breast cancer her3+ negative MNDR-E-MI-22519
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter BCL2 Homo sapiens RR00219014
TOP